Tag Archive

Dr John Skerrit appointed as new head of TGA

Published on May 3, 2012 By viva

VIVA! Communications welcomes The Commonwealth Department of Health and Ageing’s (DoHA) appointment of Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration (TGA), effective at the end of May. The TGA is the national body responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products. According to the Secretary [...]

Share

PBS administration under public inquiry

Published on July 8, 2011 By viva

The Government’s administration of the Pharmaceutical Benefits Scheme (PBS) is in the spotlight this month with a public inquiry into the deferral of medicines and possible repercussions for the pharmaceutical sector. Stakeholders have until next Friday, July 15, to submit their applications to The Finance and Public Administration References Committee for the public hearing, to [...]

Share

RNSH staff unite in last ditch attempt to counter flawed redevelopment plans

Published on March 16, 2011 By vivapaul

All quiet on the Labor front today, despite an unprecedented move by the Royal North Shore Hospital (RNSH) Medical Staff Council (MSC) to put the current ‘bed block bedlam’ to rest.  The 350-strong RNSH MSC convened a meeting today to bolster their opposition to the NSW government’s grossly under-funded and exceedingly flawed hospital redevelopment.  Dr [...]

Share

Staff uniting to combat ‘bed block bedlam’ at RNSH

Published on March 16, 2011 By vivapaul

The 350-strong membership of the Royal North Shore Hospital (RNSH) Medical Staff Council (MSC) convened an extraordinary staff meeting today (Wednesday, March 16) to oppose the New South Wales government’s grossly under-funded and exceedingly flawed hospital redevelopment plans. With the NSW election now only 10 days away, the MSC held a staff meeting that attracted [...]

Share

Campaign for life-saving treatment of PNH

Published on March 7, 2011 By vivapaul

It is with great pleasure that I write to thank you and the Viva! Communications team for your assistance with our campaign to gain Government funding of Soliris (Eculizumab), the only effective treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH). Viva! Communications began work on the campaign at a very difficult time when all PNH patients,doctors and [...]

Share